Delivery Order SPE2DB22D2206-SPE2DB25FKE69
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $111,705.60 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials. The contract, awarded on September 29, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 21, 2025. This award was competitively solicited with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Gamunex-C 40 gram/400 milliliter vials with a ceiling value of $6,981.60 and an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.40 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40 gram/400 mL immunoglobulin product, with an ultimate completion date of June 17, 2025. The award, issued May 27, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $33,528.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gamunex-C 10 gram/100 mL vials. The contract is scheduled for completion by October 17, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $14,651.28 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 10 gram/100 mL vials (100 mL quantity). This is a firm fixed-price, non-set-aside contract with a completion date of October 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $9,308.80 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials, with performance through September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply portfolio supporting federal medical procurement needs. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $27,926.40 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract, with no set-aside designation, is scheduled for completion by October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,882.24 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on September 12, 2025. This firm fixed price, competitively awarded delivery order is scheduled for completion by October 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's proven capability to compete successfully in...
- The Defense Logistics Agency awarded a delivery order valued at $28,323.36 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on September 18, 2025, with completion targeted for October 9, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $1 billion through December 2026. The company, headquartered in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKE69Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $111,324.90 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 40 gram/400 mL vials on September 29, 2025. This firm fixed price delivery order is scheduled for completion by October 21, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Gamunex-C is an immune globulin product used for treating immunodeficiency conditions and other medical needs within the Department of Defense healthcare system. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves multiple government healthcare entities including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $111.3k | 9/29/25 |